VSIR and invasive ductal breast carcinoma: Based on other findings, invasive ductal carcinoma (IDC) of breast cancer exhibits overexpression of VISTA compared to adjacent normal tissues, with an expression level of 29.1% in immune cells and 8.2% in tumor cells (42, 43).